NEULAND LABS Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NEULAND LABS Quarterly Results    (NELB)

Here are the latest quarterly results of NEULAND LABS. For more details, see the NEULAND LABS financial fact sheet and NEULAND LABS share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

NEULAND LABS Quarterly Results

No. of Mths
Qtr. Ending
3
Sep-18
3
Dec-18
3
Mar-19
3
Jun-19
3
Sep-19
3
Dec-19
3
Mar-20
3
Jun-20
8-Qtr Chart
Click to enlarge
Net Sales Rs m1,6871,7151,7271,8101,8622,0361,9192,054 
Other income Rs m64135610187 
Turnover Rs m1,6941,7191,7401,8151,8682,0461,9362,061 
Expenses Rs m1,5411,5561,5431,6241,6141,7561,6191,717 
Gross profit Rs m146158184186248281300337 
Depreciation Rs m5974697683787689 
Interest Rs m4130474048577154 
Profit before tax Rs m53598175123156171202 
Tax Rs m9131419384526451 
Profit after tax Rs m4446675686110-94151 
Gross profit margin %8.79.210.710.313.313.815.616.4 
Effective tax rate %16.922.016.825.230.529.1154.825.5 
Net profit margin %2.62.73.93.14.65.4-4.97.3 
Diluted EPS Rs 3.4 3.6 5.2 4.4 6.7 8.6 -7.3 11.7  
Diluted EPS (TTM) Rs NA NA NA 16.6 19.9 24.9 12.4 19.7  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

More Pharmaceuticals Company Quarterly Results:   DR. REDDYS LAB  CADILA HEALTHCARE  WYETH  GLENMARK PHARMA  BIOCON   

Compare NEULAND LABS With:   DR. REDDYS LAB  CADILA HEALTHCARE  WYETH  GLENMARK PHARMA  BIOCON   

Compare NEULAND LABS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Crucial Week Ahead for the Indian Stock Market(Momentum Moves)

The market scaled new life-time highs this week but it was the bears who took control. The benchmark indices, Sensex and Nifty ended mostly flat for the week but the momentum was in favour of the bears.

Views on news

NEULAND LABS 2019-20 Annual Report Analysis (Annual Result Update)

Sep 2, 2020 | Updated on Sep 2, 2020

Here's an analysis of the annual report of NEULAND LABS for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of NEULAND LABS. Also includes updates on the valuation of NEULAND LABS.

More Views on News

Most Popular

Why Gold Hit Lower Circuit (Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

Time to Book Profits in Pharma Stocks (Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

A Rare Chance to Invest in Potential Multibaggers in 2021 (Profit Hunter)

Jan 11, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

Smallcap Stocks: Your Best Bet for 2021 and Beyond (Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

NEULAND LABS SHARE PRICE


Jan 22, 2021 (Close)

TRACK NEULAND LABS

  • Track your investment in NEULAND LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON NEULAND LABS

NEULAND LABS - NATCO PHARMA COMPARISON

COMPARE NEULAND LABS WITH

MARKET STATS